Association between Skin Thickness Measurements with Corneal Biomechanical Properties and Dry Eye Tests in Systemic Sclerosis

References

• Varga J. Abraham D: systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Investig. 2007;117:557–567.
   PubMed Web of Science ®Google Scholar
• Hunzelmann N. Krieg T: scleroderma: from pathophysiology to novel therapeutic approaches. Exp Dermatol. 2010;19:393–400.
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–205.
   PubMed Web of Science ®Google Scholar
• Clements PJ, Wong WK, Hurwitz EL, et al. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum. 1999;42(11):2372–2380.
   PubMed Web of Science ®Google Scholar
• Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum. 1997;40:1984–1991.
   PubMed Web of Science ®Google Scholar
• McNearney TA, Reveille JD, Fischbach M, et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum. 2007;57(2):318–326.
   PubMed Web of Science ®Google Scholar
• Herzog EL, Mathur A, Tager AM, Feghali-Bostwick C, Schneider F, Varga J. Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?. Arthritis Rheum. 2014;66:1967–1978.
   PubMed Web of Science ®Google Scholar
• Clements PJ, Lachenbruch PA, Ng SC, Simmons M, Sterz M, Furst DE. Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum. 1990;33:1256–1263.
   PubMed Web of Science ®Google Scholar
• Bryan C, Knight C, Black CM, Silman AJ. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum. 1999;42:2660–2665.
   PubMed Web of Science ®Google Scholar
• Steen VD, Medsger TA Jr., Osial TA Jr., Ziegler GL, Shapiro AP, Rodnan GP. Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med. 1984;76:779–786.
   PubMed Web of Science ®Google Scholar
• Nevskaya T, Baron M, Pope JE. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort. Rheumatology. 2017;56:1111–1122.
   PubMed Web of Science ®Google Scholar
• Czirjak L, Foeldvari I, Muller-Ladner U. Skin involvement in systemic sclerosis. Rheumatology. 2008;47:44–45.
   PubMed Web of Science ®Google Scholar
• Ziemek J, Man A, Hinchcliff M, Varga J, Simms RW, Lafyatis R. The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis. Rheumatology. 2016;55:911–917.
   PubMed Web of Science ®Google Scholar
• Minier T, Nagy Z, Balint Z, et al. Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis. Rheumatology. 2010;49(6):1133–1145.
   PubMed Web of Science ®Google Scholar
• Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum. 1979;22:130–140.
   PubMed Web of Science ®Google Scholar
• Furst DE, Clements PJ, Steen VD, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol. 1998;25(1):84–88.
   PubMed Web of Science ®Google Scholar
• Tailor R, Gupta A, Herrick A, Kwartz J. Ocular manifestations of scleroderma. Surv Ophthalmol. 2009;54:292–304.
   PubMed Web of Science ®Google Scholar
• Gomes Bde A, Santhiago MR, Magalhaes P, Kara-Junior N, Azevedo MN, Moraes HV. Ocular findings in patients with systemic sclerosis. Clinics. 2011;66:379–385.
   PubMed Web of Science ®Google Scholar
• Waszczykowska A, Gos R, Waszczykowska E, Dziankowska-Bartkowiak B, Jurowski P. Prevalence of ocular manifestations in systemic sclerosis patients. Arch Med Sci. 2013;9:1107–1113.
   PubMed Web of Science ®Google Scholar
• Emre S, Kayikcioglu O, Ates H, et al. Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the reichert ocular response analyzer. Cornea. 2010;29(6):628–631.
   PubMed Web of Science ®Google Scholar
• Van Den Hoogen F, Khanna D, Fransen J, et al. classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–2747.
   PubMed Web of Science ®Google Scholar
• Garcia-Porta N, Fernandes P, Queiros A, Salgado-Borges J, Parafita-Mato M, Gonzalez-Meijome JM. Corneal biomechanical properties in different ocular conditions and new measurement techniques. ISRN Ophthalmol. 2014;2014:724546.
   PubMedGoogle Scholar
• Ang GS, Bochmann F, Townend J, Azuara-Blanco A. Corneal biomechanical properties in primary open angle glaucoma and normal tension glaucoma. J Glaucoma. 2008;17:259–262.
   PubMed Web of Science ®Google Scholar
• Sahin A, Bayer A, Ozge G, Mumcuoglu T. Corneal biomechanical changes in diabetes mellitus and their influence on intraocular pressure measurements. Invest Ophthalmol Vis Sci. 2009;50:4597–4604.
   PubMed Web of Science ®Google Scholar
• Yazici AT, Kara N, Yuksel K, et al. The biomechanical properties of the cornea in patients with systemic lupus erythematosus. Eye. 2011;25(8):1005–1009.
   PubMed Web of Science ®Google Scholar
• Kara N, Yildirim Y, Demircan A, et al. Topographic and biomechanical evaluation of cornea in patients with ichthyosis vulgaris. Cont Lens Anterior Eye. 2012;35(5):208–212.
   PubMed Web of Science ®Google Scholar
• Fahnehjelm KT, Chen E, Winiarski J. Corneal hysteresis in mucopolysaccharidosis I and VI. Acta Ophthalmol. 2012;90:445–448.
   PubMed Web of Science ®Google Scholar
• Kara N, Bozkurt E, Baz O, et al. Corneal biomechanical properties and intraocular pressure measurement in Marfan patients. J Cataract Refract Surg. 2012;38(2):309–314.
   PubMed Web of Science ®Google Scholar
• Tas M, Oner V, Ozkaya E, Durmus M. Evaluation of corneal biomechanical properties in patients with rheumatoid arthritis: a study by ocular response analyzer. Ocul Immunol Inflamm. 2014;22:224–227.
   PubMed Web of Science ®Google Scholar
• West RH, Barnett AJ. Ocular involvement in scleroderma. Br J Opthalmol. 1979;63:845–847.
   PubMed Web of Science ®Google Scholar
• Rentka A, Nagy A, Harsfalvi J, et al. Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis. Rheumatol Int. 2017;37(11):1835–1845.
   PubMed Web of Science ®Google Scholar